ComInnex, Inc.

May 14, 2013 12:00 ET

ComInnex Aims to Create Novel Chemicals for Pharmaceutical, Cosmetics and Fine Chemical Applications

National Development Agency grant to provide support

BUDAPEST, HUNGARY--(Marketwired - May 14, 2013) - ComInnex, Inc., a privately held contract research and integrated discovery chemistry service organization announced today that its innovative project, "Development of a flow chemistry and pyrolysis platform for pharmaceutical, cosmetics and agrochemical applications in combination with novel nanoformulation processes," gained support from the National Development Agency. Funding comes under the program, "Market-oriented research and development project support."

The aim of the project is to develop convenient and practical laboratory flow and pyrolysis technologies. These new capabilities will enable chemists to reach into an extended chemical space in a safe and effective manner that is not accessible by traditional laboratory chemistry methods. The widened chemical space will open new opportunities for the synthesis of novel skeletons or molecular frameworks.

The new innovative platform will be capable of carrying out well-controlled reactions at extremely high temperatures or pressures either as flow or traditional batch chemistry. In addition, the new platform will facilitate the production and the evaluation of numerous previously unstudied compound classes. It is anticipated that the platform will enable small and medium scale quantities in the laboratory.

"Innovation to expand the chemical space can have tremendous benefits to our customers," said Gergely Makara, CEO. "The cost of finding new chemicals is extremely high under current methods so we are very excited about the potential that we can bring to the chemical community."

About ComInnex:

ComInnex, Inc. is a custom chemistry, medicinal chemistry and chemical library provider in the EU with strong background in new chemical technologies. Its chemistry, medicinal chemistry and technology platform was formed via the fusion of powerful chemistry technology innovation at ComInnex with the outstanding chemistry and medicinal chemistry expertise of the former AMRI Hungary. Beyond offering excellence in traditional contract research, the company is also a breeding ground for innovative technologies in the service of chemistry and medicinal chemistry research: a partner where technology and medicinal chemistry meet to access novel and unique chemical space.

Board of Directors: Dr. Ferenc Darvas, Dr. Laszlo Urge, Alex Drijver, Erzsebet Tari Palne.

Contact Information